Literature DB >> 17214551

Asef is a Cdc42-specific guanine nucleotide exchange factor.

Katja Gotthardt1, Mohammad Reza Ahmadian.   

Abstract

Asef is a member of the Dbl-family of guanine nucleotide exchange factors (GEFs) with a proposed specificity for the small GTPase Rac1. Here we investigated the specificity and regulation of Asef by measuring its GEF activity in vitro and observed hardly any activity towards Rac1, Rac2 and Rac3, or RhoA and TC10. In contrast, various purified Asef protein fragments catalyzed the nucleotide exchange reaction of Cdc42. The Cdc42GEF activity of the Dbl homology (DH) domain of Asef was significantly higher in the presence of the pleckstrin homology (PH) domain. Our data strongly suggest that Asef is a canonical Cdc42GEF, which employs its PH domain to efficiently stabilize its autoinhibited state, but also to facilitate nucleotide exchange activity of the DH domain after its activation by upstream signals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17214551     DOI: 10.1515/BC.2007.008

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  15 in total

1.  Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression.

Authors:  Natalia Mitin; Laurie Betts; Marielle E Yohe; Channing J Der; John Sondek; Kent L Rossman
Journal:  Nat Struct Mol Biol       Date:  2007-08-19       Impact factor: 15.369

2.  Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG).

Authors:  Mamta Jaiswal; Lothar Gremer; Radovan Dvorsky; Lars Christian Haeusler; Ion C Cirstea; Katharina Uhlenbrock; Mohammad Reza Ahmadian
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

3.  Structural basis for the recognition of Asef by adenomatous polyposis coli.

Authors:  Zhenyi Zhang; Leyi Chen; Lei Gao; Kui Lin; Liang Zhu; Yang Lu; Xiaoshan Shi; Yuan Gao; Jing Zhou; Ping Xu; Jian Zhang; Geng Wu
Journal:  Cell Res       Date:  2011-07-26       Impact factor: 25.617

Review 4.  Adenomatous Polyposis Coli (APC) in cell migration.

Authors:  Xingyuan Fang; Tatyana M Svitkina
Journal:  Eur J Cell Biol       Date:  2022-04-22       Impact factor: 6.020

5.  Novel association of APC with intermediate filaments identified using a new versatile APC antibody.

Authors:  Yang Wang; Yoshiaki Azuma; David B Friedman; Robert J Coffey; Kristi L Neufeld
Journal:  BMC Cell Biol       Date:  2009-10-21       Impact factor: 4.241

6.  Structural basis for autoinhibition of the guanine nucleotide exchange factor FARP2.

Authors:  Xiaojing He; Yi-Chun Kuo; Tyler J Rosche; Xuewu Zhang
Journal:  Structure       Date:  2013-01-31       Impact factor: 5.006

7.  The adenomatous polyposis coli-associated guanine nucleotide exchange factor Asef is involved in angiogenesis.

Authors:  Yoshihiro Kawasaki; Takafumi Jigami; Shiori Furukawa; Masaki Sagara; Kanae Echizen; Yoko Shibata; Rina Sato; Tetsu Akiyama
Journal:  J Biol Chem       Date:  2009-11-06       Impact factor: 5.157

8.  The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in Apc(Min/+)mice.

Authors:  Yoshihiro Kawasaki; Shinnosuke Tsuji; Ken Muroya; Shiori Furukawa; Yoko Shibata; Masumi Okuno; Susumu Ohwada; Tetsu Akiyama
Journal:  EMBO Rep       Date:  2009-11-06       Impact factor: 8.807

9.  Adenomatous polyposis coli and Asef function downstream of hepatocyte growth factor and phosphatidylinositol 3-kinase.

Authors:  Yoshihiro Kawasaki; Shinnosuke Tsuji; Masaki Sagara; Kanae Echizen; Yoko Shibata; Tetsu Akiyama
Journal:  J Biol Chem       Date:  2009-06-12       Impact factor: 5.157

Review 10.  Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer Therapy.

Authors:  Xiuyan Yang; Jie Zhong; Qiufen Zhang; Li Feng; Zhen Zheng; Jian Zhang; Shaoyong Lu
Journal:  Front Mol Biosci       Date:  2021-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.